Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $38.60 $44.37 Friday, 10th May 2024 XENE stock ended at $40.54. This is 4.59% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.26% from a day low at $38.60 to a day high of $42.56.
90 days $38.60 $50.99
52 weeks $27.99 $50.99

Historical Xenon Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Dec 15, 2023 $41.38 $42.05 $40.00 $41.41 786 512
Dec 14, 2023 $40.54 $41.28 $39.23 $41.24 1 219 513
Dec 13, 2023 $39.72 $40.24 $38.81 $39.90 369 380
Dec 12, 2023 $38.33 $39.95 $37.95 $39.68 460 248
Dec 11, 2023 $38.39 $38.66 $37.24 $38.33 502 765
Dec 08, 2023 $39.37 $40.34 $38.25 $38.34 311 120
Dec 07, 2023 $38.84 $39.44 $38.23 $39.04 429 926
Dec 06, 2023 $38.89 $39.46 $38.26 $38.63 759 215
Dec 05, 2023 $37.91 $38.78 $37.20 $38.74 497 075
Dec 04, 2023 $37.20 $37.90 $35.75 $37.76 792 213
Dec 01, 2023 $35.82 $37.60 $35.77 $36.80 653 679
Nov 30, 2023 $35.45 $38.13 $35.18 $36.58 2 678 465
Nov 29, 2023 $35.30 $36.11 $33.74 $33.75 366 957
Nov 28, 2023 $34.42 $35.75 $33.63 $35.24 1 015 280
Nov 27, 2023 $29.00 $34.26 $29.00 $34.12 3 347 860
Nov 24, 2023 $28.74 $29.16 $28.20 $28.97 346 609
Nov 22, 2023 $30.19 $30.25 $28.55 $28.73 406 385
Nov 21, 2023 $28.89 $30.05 $28.77 $30.03 554 589
Nov 20, 2023 $29.46 $29.90 $28.75 $29.09 351 766
Nov 17, 2023 $29.08 $29.67 $28.48 $29.44 505 459
Nov 16, 2023 $29.19 $29.19 $28.11 $28.70 526 948
Nov 15, 2023 $29.67 $30.05 $29.12 $29.15 540 488
Nov 14, 2023 $30.44 $31.16 $29.54 $29.75 642 416
Nov 13, 2023 $28.62 $29.95 $27.99 $29.70 605 084
Nov 10, 2023 $29.65 $30.35 $28.55 $28.83 761 032
Click to get the best stock tips daily for free!

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o... XENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT